These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

868 related items for PubMed ID: 18094421

  • 1. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    Clin Cancer Res; 2007 Dec 15; 13(24):7388-93. PubMed ID: 18094421
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
    Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Bergh A, Ljungberg B.
    Eur Urol; 2006 Dec 15; 50(6):1272-7. PubMed ID: 16814458
    [Abstract] [Full Text] [Related]

  • 3. [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma].
    Shao ZQ, Zheng SB, Xiao YJ, Tan WL, Chen T, Qi H, Jiang YD, Yu ZC, Zhang HJ.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug 15; 25(8):1034-6. PubMed ID: 16109571
    [Abstract] [Full Text] [Related]

  • 4. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
    Lidgren A, Bergh A, Grankvist K, Rasmuson T, Ljungberg B.
    BJU Int; 2008 Feb 15; 101(4):480-4. PubMed ID: 17922867
    [Abstract] [Full Text] [Related]

  • 5. The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma.
    Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Vasko J, Ljungberg B.
    Clin Cancer Res; 2005 Feb 01; 11(3):1129-35. PubMed ID: 15709180
    [Abstract] [Full Text] [Related]

  • 6. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
    Klatte T, Seligson DB, LaRochelle J, Shuch B, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    Cancer Epidemiol Biomarkers Prev; 2009 Mar 01; 18(3):894-900. PubMed ID: 19240241
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
    Tickoo SK, Alden D, Olgac S, Fine SW, Russo P, Kondagunta GV, Motzer RJ, Reuter VE.
    J Urol; 2007 Apr 01; 177(4):1258-63. PubMed ID: 17382701
    [Abstract] [Full Text] [Related]

  • 8. Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation.
    Ku JH, Park YH, Myung JK, Moon KC, Kwak C, Kim HH.
    Urol Oncol; 2011 Apr 01; 29(6):731-7. PubMed ID: 19914104
    [Abstract] [Full Text] [Related]

  • 9. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
    Michelsen J, Thiesson H, Walter S, Ottosen PD, Skøtt O, Jensen BL.
    Clin Sci (Lond); 2006 Jul 01; 111(1):61-70. PubMed ID: 16515534
    [Abstract] [Full Text] [Related]

  • 10. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.
    J Urol; 2008 Oct 01; 180(4):1284-9. PubMed ID: 18707725
    [Abstract] [Full Text] [Related]

  • 11. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
    Cancer; 2003 Mar 15; 97(6):1573-81. PubMed ID: 12627523
    [Abstract] [Full Text] [Related]

  • 12. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB.
    Br J Cancer; 2007 Jun 18; 96(12):1888-95. PubMed ID: 17505508
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS.
    Cancer; 2005 Jun 15; 103(12):2517-25. PubMed ID: 15880379
    [Abstract] [Full Text] [Related]

  • 14. Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.
    Miyake H, Sakai I, Muramaki M, Kurahashi T, Takenaka A, Fujisawa M.
    Int J Urol; 2009 May 15; 16(5):465-71. PubMed ID: 19467119
    [Abstract] [Full Text] [Related]

  • 15. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT, Cai ZM, Li NC, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 25; 86(28):1970-4. PubMed ID: 17064593
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
    Sandlund J, Ljungberg B, Wikström P, Grankvist K, Lindh G, Rasmuson T.
    Acta Oncol; 2009 Jul 25; 48(6):909-14. PubMed ID: 19322701
    [Abstract] [Full Text] [Related]

  • 17. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.
    Theodoropoulos VE, Lazaris ACh, Sofras F, Gerzelis I, Tsoukala V, Ghikonti I, Manikas K, Kastriotis I.
    Eur Urol; 2004 Aug 25; 46(2):200-8. PubMed ID: 15245814
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T, Furuya M, Nishiyama M, Kasuya Y, Kimura S, Ichikawa T, Ueda T, Nikaido T, Ito H, Ishikura H.
    Cancer; 2005 Jan 15; 103(2):258-67. PubMed ID: 15578685
    [Abstract] [Full Text] [Related]

  • 19. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
    Konda R, Sugimura J, Sohma F, Katagiri T, Nakamura Y, Fujioka T.
    J Urol; 2008 Aug 15; 180(2):481-5. PubMed ID: 18550099
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.
    Urology; 2007 May 15; 69(5):843-8. PubMed ID: 17482919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.